Group name
Whole-gland treatment (Total)
Groups definition
patients underwent sRARP after focal or whole-gland primary treatment
T2
21 (47)
T3
GS 6
0 (0)
GS 3+4
14 (31)
GS 4+3
18 (40)
GS 8
3 (6)
GS 9
11 (24)